throbber
876
`
`3' Chit HIM 1995;48:876-373
`
`A “quickscore” method for
`immunohistochemical semiquantitation:
`validation for oestrogen receptor in breast
`carcinomas
`
`S Detre, G Saccani Jotti, M Dowsett
`
`Abstract
`increasingly
`hnmunohistochemistry is
`used in the assessment of markers for
`breast cancer prognosis. Semiquanu'tation
`is frequently desirable but, other than by
`the use of image analysis, the appmaches
`currently in use are cumbersome. The
`most common method used is the H-score
`which takes into consideration the staining
`intensity in conjunction with the per-
`centage ofcells staining positively in breast
`carcinoma tissue. A “quickscore” has been
`developed which dispenses with the need
`to count individual cells. The quantitative
`biochemical Abbott enzyme immunoassay
`(BIA) and the Dako immunohistochemicsl
`assay (ll-IA) incorporating a semiquan-
`tiunive H-score, have been used as stand-
`ards against which the IRA quickscore for
`the semiquantitation ofoestrogen receptor
`expression was tested. A good correlation
`was found between the quickscore and the
`EIA, which was as good as that between
`the H-score and EIA. The quickscore is a
`valid approach and there is no advantage
`in using the more rigorous H—score. A
`positive cut 011' quickscore of 2 3 has been
`suggested.
`(3 Clip: Parka! 1995;48:876—879)
`
`Immunolflstochemisuy, quickscore, oes-
`Keywords:
`trogen receptor, breast cancer.
`
`involves the addition of scores for staining in-
`tensity and the proportion of positive cells,
`which is a departure from the H—score which
`is based on multiplication of these components
`and intuitively is more appropriate if staining
`intensity reflects antigen concentration. The
`aim of this study was to asseSs whether a mo-
`dification of the quickscore to a multiplicative
`form was valid and could provide an acceptable
`alternative to the H—score. Two extra categories
`for the proportion of cells staining positively
`were also included to permit a completely neg-
`ative result, and to take into account the pres-
`ence of very small numbers of positive cells.
`
`Methods
`Ninety six primary breast cancer surgical speci-
`mens, embedded in paraflin wax, were studied.
`These tumours were taken from a cohort of
`
`119 untreated patients studied previously5 and
`the oestrogen receptor EIA, using the Abbott
`H222 antibody, and the oestrogen receptor
`IHA, using the Dako lD5 antibody, have been
`described in detail. The reduction in sample
`size to 96 tumours was necessary because 17
`mismatches had occurred between EIA and
`IHA pairs of results and in order not to con-
`found the scoring appraisal these mismatches
`were excluded from this investigation. A further
`six mmours were excluded because full results
`were not available.
`
`Oestrogen receptor determination is important
`in the study of the biology of breast cancers
`and for determining the clinical implications of
`hormone n-eaunenr.’ Recently, the immuno-
`histochemical assay (Ii-IA) has gained favour
`over the gold standard enzyme immunoassay
`(EIA) because it is cheaper, quicker and easier
`to perform and enables direct visualisation of
`malignant tumour receptor localisation in small
`tissue samples.“ One disadvantage of the im-
`munohistochemical approach is the laborious
`H—score procedure which is prone to a degree
`of discordance between sssessorv.:..I
`As the immunohlstochemical approach is
`gaining increasing support
`for
`routine as-
`sessment of oestrogen receptor expression, a
`more rapid scoring scheme would be useful
`especially when appraising large numbers of
`Sections from clinical studies. To this end a
`quickseore method such as that suggested by
`Barnes er a!‘ would expedite matters. The
`method described by Barnes er al, however,
`
`SCORING ASSESSMENT
`
`For H—score assessment, 10 fields were chosen
`at random or x 400 magnification and the stain-
`ing intensity in the malignant cell nuclei was
`scored as 0, 1, 2, or 3 corresponding to the
`presence of negative, weak, intermediate, and
`strong brown staining, respectively. The total
`number of cells in each field and the number
`of cells stained at each intensity were counted.
`The average percentage positive was calculated
`and the following formula3 was applied:
`IHA Hecore=(% of cells stained or intensity category
`1 x 1) + (% of cells
`stained at
`intensity category
`2 x 2) + (is of cells stained at intensity category 3 x 3).
`
`A H—scorc between 0 and 300 was obtained
`where 300 was equal to 100% of tumour cells
`stained strongly (3 4-).
`The immunohistochemicslly stained sec-
`tions were subsequently given a quickscore
`independently by two of the authors without
`prior consultation or recourse to clinical, bio-
`
`Genome & Co. v. Univ. of Chicago, PGR2019-OOOO2
`UNIV. CHICAGO EX. 2077
`
`academic
`of Biochemistry,
`Royal Mandela
`Hospital,
`Fulbam Road.
`London SW3 6]]
`S Detre
`M Dawson
`
`Istituto di Anatomia
`ed Istologla
`Patologica,
`University of Par-ms,
`Italy
`G Ssccsni Jodi
`[‘1me: to:
`S Den-e.
`Accepted for publication
`17 Ianuary 1995
`
`

`

`Qm‘ckscors for immanohirtochemicni smiqmnrimrion
`
`87‘?
`
`T5538 3 _ SWIM“ “I”? 50mm" WW fl?"
`mjmffl Wmmfifl" ”1' “mg“ m”
`
`scores and a good positive correlation was ob-
`served between the IHA and the EIA (table 1).
`More importantly, the correlation between both
`of the quickscores and the EIA was very similar
`”‘0'
`cmmn" ”rm dm‘
`to that for the H—score and the EIA.
`can:
`Q=AxB v H score
`We also compared the performance of the
`3:23;
`331:1;2 ELI-lam"
`two quickscore approaches with two separate
`0'83]
`Q=axB 13 Em
`ease
`Q=a+aesia
`— assessors. Total agreement of score occurred
`rho.=regression coefficient corrected for ties; Q-quieirscore
`in 73% of cases and demonstrated a very strong
`gfimmfim flags” "“9“" ”mm" ”1‘5””
`correlation between the multiplicative and ad-
`mit-0001
`ditive quickscore (rho,=0'994). In the seven
`cases where disagreement occurred, five were
`at
`the highest
`score levels—for example,
`chemical or previously recorded H—score data. A x B =18 and 15, A +B = B and 9, and two at
`The quickscore categories were based on both
`the lowest levels—for example, A x B =1 and
`the intensity and the proportion of brown stain-
`2, A+B = 2 and 3. The maximum quickscore
`ing nuclei. In our modification the proportion was attained in many cases, especially where
`of malignant cells staining positively through-
`high EIA values occurred. Interestingly, a very
`out the section was termed category A and was
`high H—score level was never achieved.
`assigned scores from 1 to 6 (l=0—4%; 2=
`549%; 3 = 20—39%; 4 =40—59%; 5 = 60—79%;
`6:80—100%). The whole section was scanned Discussion
`at low power in order to gauge the general level The concordance between the two observers
`of intensity throughout. The average intensity,
`indicates that both quickscores are repro-
`corresponding to the presence of negative,
`ducible although more studies from other
`weak, intermediate, and strong staining, was
`laboratories are necessary to confirm this. The
`given a score from 0 to 3, respectively, and
`l'HA quickscore compared favourably with the
`termed category B. Category A was added to
`gold standard BIA. That the quickscore is of
`category B (A+B) to form an additive quick— equivalent value to the H-score, when using
`score and recorded in parallel with the product
`the same irnrnunohistochernical technique, was
`(A x B) as a multiplicative quickscore. The res-
`confirmed by the good Spearman rank cor—
`ults were tabulated and EIA and IHA results
`relation between them.
`were compared with the quickscore using
`The reason why these sections did not have
`Speannan rank correlation statistics.
`very high H—scores could have been because
`tumours in this cohort expressed oestrogen
`receptor at a low level. This, however, was not
`the case when the quickscore was applied as
`Results
`The EIA values ranged from 0 to 597 fmolesr‘ maximum scores were reported in 19% (GSJ)
`mg protein and 62% of the tumours were
`and 14% {SD} of cases.
`oestrogen receptorpositive {cutoff ?10 fmoles/
`The quickscore seems to be less prone to
`mg protein). H—scores
`ranged from 0 to
`variation than the H—score because the observer
`190. Additive and multiplicative quickscores
`evaluates the whole section, estimating an over—
`covered the full range—that is, CA+ B) = 1—9
`all impression of intensity when scoring and not
`and (A x B) =0—18, respectively. Table 1 shows
`inst 10 representative, but randomly selected,
`a comparison ofthe Spearman rank correlations
`high power fields. This difference in approach
`for the three oestrogen receptor methods and might explain the underestimation of H—score.
`the individual categories of the AxB quick-
`The positive cut off for the EIA is usually
`some are compared with intervals of H-scores
`10 Emolesfmg protein in breast carcinomas.”7
`and EIA in table 2. There was no difference The positive cut off using the IHA is more
`between the additive and multiplicative quick-
`contentious and varies from a H—score of 20,
`
` 0 i' 2 .i' H 8 to 1'2 :5 :3 "Rural
`
`
`
`
`
`
`
`29
`2
`I}
`D
`0
`0
`
`0
`3
`1‘
`I}
`D
`I}
`
`D
`2
`0
`O
`D
`O
`
`0
`0
`2
`D
`I)
`0
`
`0
`(I
`l
`3
`o
`[I
`
`D
`D
`3
`5
`0
`0
`
`D
`O
`D
`5
`8
`O
`
`0
`0
`0
`4
`lo
`O
`
`0
`D
`i]
`l
`3
`U
`
`D
`D
`I}
`2
`12
`D
`
`29
`T
`‘3
`20
`33
`D
`
`
`
`
`
`
`
`
`
`
`Table 2 Freon-my of multiphase qmehtomr in [Hid and EM result when
`Quichmore =2! 3: B
`
`
`H—soore
`G
`1— I 9
`20-49
`50—99
`too-199
`200-300
`Em
`36
`0
`D
`i]
`I)
`O
`I]
`O
`2
`3
`31
`59
`24
`2
`2
`a
`5
`7
`2
`I
`o
`l"
`I)
`10—49
`16
`2
`I
`4
`5
`l
`2
`I
`o
`I}
`I)
`50-99
`12
`5
`I
`5
`I
`I]
`D
`o
`0
`O
`I)
`100—199
`5
`3
`0
`l
`1
`D
`D
`O
`D
`0
`0
`200-29?
`1
`l
`O
`O
`O
`I]
`o
`o
`i]
`0
`0
`300—399
`a
`D
`0
`0
`D
`D
`O
`0
`I)
`0
`0
`400499
`2
`l
`o
`(1|
`1
`0
`0
`{I
`D
`0
`0
`500-600
`
`
`
`
`
`
`
`
`
`
`
`31 4 2 2 4 8 I3 14 4 14Total 9'6
`‘ =32; "‘ = 29 I'Inolesimg protein.
`.
`Negative H—score s 19.
`Negative EIA 59$:qu protein.
`
`

`

`878
`
`in our laboratory,5 to 50—100 in others.” Bear-
`ing in mind our laboratory cut off values, table
`2 shows a logical demarcation between the
`positive and negative EIA and IHA subsets
`at a multiplicative quickscore ?3. Thirty six
`breast
`tumours with negative EIA results
`($9finoleslmg protein) occurred in the 0—2
`quichcore subset; no oestrogen receptor neg-
`ative breast tumours on EIA were reported in
`the 3—18 quickscore subset whereas 59 of 60
`oestrogen receptor positive breast cancers were
`observed in this classification. Only one of 60
`oestrogen receptor EIA positive tumours was
`present in the 0-2 quickscore subset. The same
`results were obtained using a H-score cut off
`<20. The one tumour negative on assessment
`using the quickscore but positive by II-IA (H-
`score=32)
`and
`oestrogen
`receptor-BIA
`(29 fmolesfrng protein) came from the same
`patient.
`The results also show that there is no differ-
`ence between adding or multiplying categories
`A and B. The additive approach, with a range
`from 1 to 9, has two disadvantages. Firstly, the
`additive (A+B) quickscore does not permit a
`completely negative result, which occurred in
`many of our oestrogen receptor negative cases,
`whereas the multiplicative (Ax B) quickscore
`does. Secondly, the range is small for the ad-
`ditive quickscore. Considering the wide range
`
`Dem, Scream‘Jorn, Dossier:
`
`of values within the quantitative methods, the
`multiplicative quickscore, ranging from O to
`18, is preferable. Without prejudicing accuracy,
`the quickscore approach takes about a quarter
`of the time taken when calculating the H—score
`because it dispenses with the need to count
`individual cells.
`
`G Saocani Jerri was supported in part by the following grants:
`CNR ACRE} Proiect. CNR Bilateral 94.021.32.61'04 and
`MURST 40% (Italy). 513 and MD were suppormd by the
`Cancer Research Campaign.
`
`1 Osborne CK. Receptors. In: HatrisIR, Helmet: 5. Henderson
`IC. Kinne DW. eds. Breast domes. Philadelphia: IE Lip-
`pincort, 199l:301-25.
`2 Andersen]. Denomination of oestrogen receptors in parami—
`emhedded tissue. Am Chiral 1992;31:611-27.
`3 McClelllnd RA, Finlay P, Walker KL Nicholson D, Rob-
`ertson IFR, Blarney RW, er of Automated quantitation
`of unmanocytuehemieally localised oestrogen receptors in
`human breast cancer. Cow Rs: ”9050:3545-50
`4 Barnes DM. Dublin EA. Fisher C], Levison DA, Millis
`RR Intrnuaohisroeheaneal detection of p53 protein in
`mammary carcinoma. Hm Parke! 1993;“:46946.
`5 Saccani Jerri G, Johnston 5111), Salter J, Detre S, Dowsett
`M. Comparison of a new immunohistocbemieal assay for
`oestrogen receptoeinparaflinwaaemheddedbreast ear-
`cinonu tissue with quantitative enzyme immunoassay 3‘
`Gift! Herbal 199-1547:900-5
`6 Andersen], Bennett SM, Poulsea HS. Relationship between
`radioligand bin '
`assay, humunoenzyme assay and im-
`muaohistochemi may for oestrogen receptors in human
`breast cancer and association with rumour difi’erentiarion.
`Ear } Cm 19381437744.
`7 Kmsei B. Saabo E. Greene 61., Konrad: J. Leight GS,
`McCarty KS. Immuooqtoehemieal analysis of oestrogen
`receptors as a predictor of prognosis in breast cancer
`patients:
`comparison with
`quantitative
`blodiemical
`methods. Cancer Res 1989348305245.
`
`3 are: Puma: 1995;423:3713—3530
`
`Granulomatous bone marrow inflammation
`
`during treatment of chronic myeloid leukaemia
`with interferon alpha-2b
`
`A Siboni, T Mounts-Andersen, J Moesner
`
`Abstract
`study, partial cytogenetic response and tem-
`A patient with chronic myeloid leukaemia
`porary morphological remission was seen in
`developed bone marrow granuloroaa dur-
`46!?1 patients.‘ Interferon alpha is used in the
`treatment of both infectious and malignant
`ing treatment with interferon alpha-2b.
`Some gsanulomas had necrotic centres
`diseases.”I One of its mechanisms of action may
`and giant cells and there was marked eoa— be inhibition of formation of new blood vessels
`inophilia surrounding them. Tile gran-
`(antiangiog'enesis) in tumour areas.2
`trans-
`alumna disappeared when the interferon
`Bone marrow necrosis at blast
`treatment was
`discontinued. Myco-
`formation of chronic gt‘anulocytic leukaemia
`bacterioais was ruled out. The most likely
`treated with interferon has been described by
`explanation for the granuloma formation Kendra et al,’ but the formation ofbone marrow
`was drug hypersensitivity.
`granulomas during the treattnent of chronic
`{5’ can Pedro! 1995;48:370-380)
`myeloid leukaemia with IFN-a-Zb has not been
`described before.
`
`Keywords: interferon, bone marrow granulomas.
`
`The treatment of chronic myeloid leukaemia Case report
`with interferon alpha-2b (IFN-or—Zb) prolongs
`A 43 year old man was referred in August 1992
`survival if cytogenic response occurs: in one
`because ofa leucocyte count of89 x lD'i'l. Bone
`
`$3,“:(Emmy
`Bit-6100 Elbifl'zs
`mm“ll let
`and M010"
`A Siboni
`T Mc'mts‘hndgfiun
`Wm of
`Podium
`I Mm"
`Cowman“ In:
`Dr Anders steam,
`Sholebakken smash.
`Bfiflgfi'b’m
`'
`a
`ted in
`oil
`1 December 1994
`r p“ mm
`ma
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket